Fenwick Expands New York Healthcare Regulatory Practice
The firm adds a new partner to help life sciences clients navigate complex regulatory and legal landscapes.
Updated on Oct. 29, 2026 in Healthcare

Fenwick has hired Roger Cohen as a partner in its New York office to support its healthcare regulatory practice. Cohen joins a firm-wide bench of over 600 professionals as the practice continues to grow its presence in the life sciences sector.
Why it matters
The firm is scaling its regulatory capabilities to better support technology and life sciences clients facing increasingly complex healthcare compliance landscapes. This addition reflects a broader strategy of integrating legal expertise with specialized industry knowledge in high-growth, regulated markets.
Fenwick now employs over 600 lawyers, patent agents, engineers, and scientists across its offices. This hiring follows a series of recent partner additions in New York and Washington, D.C. throughout 2026.
The players
Roger Cohen
A newly appointed partner joining the firm's New York office to focus on healthcare regulatory law.
Fenwick
A law firm with over 600 professionals that provides legal services to the technology and life sciences industries.
The details
Cohen will integrate with the firm's existing corporate, intellectual property, and litigation teams. By embedding regulatory counsel directly into these practice areas, Fenwick provides clients with a unified approach to navigating the intersection of clinical development and commercial law. This structure is designed to mitigate operational bottlenecks for life sciences firms by addressing regulatory risks during the early stages of product development.
Timeline
October 28, 2026: Fenwick announces the hiring of Roger Cohen.
Earlier in 2026: Fenwick hired partners Krishnan Padmanabhan, Alexander Rea, Scott Border, and Anna Uhls.
Market Landscape
This move follows the documented industry trend of firms aggressively expanding specialized healthcare regulatory practices in major financial hubs. Fenwick is positioning itself alongside competitors that prioritize integrated legal and technical support for life sciences companies.
Operators in life sciences should watch how firms align regulatory counsel with litigation and IP teams to streamline complex product development cycles. Evaluate whether your current legal partners have the specialized technical bench required to handle evolving regulatory mandates.
The takeaway
The integration of regulatory expertise into broader corporate and IP teams is becoming a critical differentiator for law firms serving the life sciences sector. Leaders should track how these expanded legal capabilities impact their own timelines for regulatory approval and commercialization.
Further reading
For more on how shifts in firm staffing impact regional life sciences, see Healthcare.





